WallStreetZenWallStreetZen

NASDAQ: ANIP
Ani Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Ani Pharmaceuticals revenue was $614.38M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $190.6M, up 28.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ANIP annual revenue was $614.4M, with 26.2% growth year-over-year.

ANIP past revenue growth

How has ANIP's revenue growth performed historically?

Company
26.2%
Industry
10.38%
Market
20.68%
ANIP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ANIP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ANIP's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ANIP revenue history

Current Revenue
$614.4M
Current Earnings
-$20.1M
Current Profit Margin
-3.3%

Be the first to know when ANIP announces revenue.

ANIP Revenue History By Year

ANIP Yearly RevenueANIP RevenueANIP ChangeANIP Revenue Growth
2024-12-31$614.38M$127.56M+26.20%
2023-12-31$486.82M$170.43M+53.87%
2022-12-31$316.39M$100.25M+46.38%
2021-12-31$216.14M$7.66M+3.67%
2020-12-31$208.48M$1.93M+0.93%
2019-12-31$206.55M$4.97M+2.47%
2018-12-31$201.58M$24.73M+13.99%
2017-12-31$176.84M$48.22M+37.49%
2016-12-31$128.62M$52.30M+68.53%
2015-12-31$76.32M$20.35M+36.36%
2014-12-31$55.97M$25.89M+86.06%
2013-12-31$30.08M$27.78M+1,207.49%
2012-12-31$2.30M$1.87M+428.71%
2011-12-31$435.16k-$2.04M-82.41%
2010-12-31$2.47M$1.22M+96.67%
2009-12-31$1.26M-$2.52M-66.73%
2008-12-31$3.78M$3.29M+666.82%
2007-12-31$493.05k-$13.94M-96.59%
2006-12-31$14.44M$14.18M+5,496.12%
2005-12-31$258.00k$180.00k+230.77%
2004-12-31$78.00k$12.51k+19.09%
2003-12-31$65.49k-$2.70M-97.64%
2002-12-31$2.77M$1.02M+58.53%
2001-12-31$1.75M$1.52M+667.35%
2000-12-31$227.72k$29.04k+14.61%
1999-12-31$198.68kN/AN/A
1998-12-31$0.00N/AN/A
1997-12-31$0.00N/AN/A

1 of 2

Ani Pharmaceuticals Revenue FAQ

What was ANIP's revenue last quarter?

On Invalid Date, Ani Pharmaceuticals (NASDAQ: ANIP) reported Q4 2024 revenue of $190.57 million up 44.75% year over year. In the same quarter last year, Ani Pharmaceuticals's revenue was $131.65 million.

What was Ani Pharmaceuticals's revenue in 2024?

Ani Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $614.38 million, a 26.2% increase year over year.

How much does Ani Pharmaceuticals make in a day?

Based on Ani Pharmaceuticals annual revenue for the past five years, ANIP makes an average of $1,009,418.08 per day.

What was Ani Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Ani Pharmaceuticals's revenue has grown 26.2% year over year. This is 15.83 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.38%. Ani Pharmaceuticals's revenue in the past year totaled $614.38 million.

How much does Ani Pharmaceuticals make in a year?

Ani Pharmaceuticals's revenue by year for the past five years is:
  • Ani Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $614.38 million, a 26.2% increase year over year.
  • Ani Pharmaceuticals's annual revenue for Dec 31, 2023 was $486.82 million, a 53.87% increase from 2022.
  • Ani Pharmaceuticals's annual revenue for 2022 was $316.39 million, a 46.38% increase from 2021.
  • Ani Pharmaceuticals's annual revenue for 2021 was $216.14 million, a 3.67% increase from 2020.
  • Ani Pharmaceuticals's annual revenue for 2020 was $208.48 million, a 0.93% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.